Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Shortages: Is "Buy American" One Solution?

Executive Summary

Moving more manufacturing to the US could help increase supply chain reliability, which could prevent or blunt shortages, an industry representative argues.

Advertisement

Related Content

Make Them In Europe: The French Solution To Drug Shortages
Could US Solve Drug Shortages With 'Heightened' M&A Scrutiny?
FDA Shortages Task Force Looks More Broadly To Tackle Root Causes
US FDA Quality Metrics Initiative Continues Moving Forward … Quietly
As Saline Shortages Persist, Providers Pin Hopes On Feds Demanding Backup Manufacturing Capacity
FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan
Generic Rx Shortage Initiative Stuck: Too Few Manufacturers To Pick Up Slack
Generic Industry Wants Private Clearinghouse For Drug Supply Information

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124344

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel